To view or add a comment, sign in Pfizer files second lawsuit against Novo Nordisk, Metsera in bidding war over obesity biotech by The suit escalates a battle between Pfizer and Novo Nordisk over Metsera, whose obesity pipeline could yield new competitors in the weight loss drug market
The Healthletic BPC-157 supplement referenced throughout this article is not approved by the U.S
Typically, these involve both a radial and horizontal tear
Your primary goal if you want to live longer is to lose excess body fat, not just weight
Unlike the rest of your skin, lips lack protective oil glands, making them more vulnerable to external and internal stressors
Given the size of the market opportunity relative to the firm's current valuation, which is noted as four billion dollars, the company could become an acquisition target